Weiss Ratings restated their sell (d-) rating on shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) in a report released on Saturday morning,Weiss Ratings reports. A number of other ...
RBC Capital analyst Darko Mihelic maintained a Buy rating on Sun Life Financial (SLF – Research Report) yesterday and set a price target of ...
On Friday, Exelixis Inc (EXEL) stock saw a decline, ending the day at $36.2 which represents a decrease of $-0.35 or -0.96% from the prior close of $36.55. The stock opened at $36.76 and touched a low ...
Victory Capital (NASDAQ:VCTR – Free Report) had its target price upped by Barclays from $69.00 to $70.00 in a report released on Friday morning,Benzinga reports. Barclays currently has an equal weight ...
British investment bank Barclays said on Monday it has appointed former Goldman Sachs banker Paul Johnson as head of equities ...
In a report released on January 16, Gerard Cassidy from RBC Capital maintained a Buy rating on PNC Financial (PNC – Research Report), with a ...
The Municipal Securities Rulemaking Board Thursday announced the members of its 2025 advisory groups, including those tapped for a new group that will focus on the intersection of technological ...
Standard Chartered printed a $1bn four year non-call three bond at 105bp over US Treasuries, and a $1bn 11 year non-call 10 ...
Deep-pocketed investors have adopted a bullish approach towards 3M MMM, and it's something market players shouldn't ignore.
BMO Capital Markets has recently reduced Exelixis Inc (EXEL) stock to Market Perform rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 17, 2024, BofA Securities had ...
Swiss luxury group Richemont said it saw an improvement across all business areas and reported better-than-expected sales for its fiscal third quarter, in the midst of a downward trend in demand for ...
After the boom in demand following the peak of the pandemic, the luxury industry slipped into a downward trend, as high-end shoppers--particularly those less affluent--have become more frugal in light ...